secwatch.observer — SEC 8-K summary
======================================

Issuer:     CNS Pharmaceuticals, Inc. (CNSP)
CIK:        0001729427
Form:       8-K
Filed at:   2025-05-15T23:59:59+00:00
Accession:  0001683168-25-003575
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CNS Pharmaceuticals raises ~$5.0M in public offering of stock and warrants
--------------------------------------------------------------------------

- Offering of 325,000 shares, 3,627,570 pre-funded warrants, and 3,952,570 common warrants.
- Combined purchase price: $1.265 per share+common warrant, $1.264 per pre-funded+common warrant.
- Gross proceeds ~$5.0M; net proceeds for working capital and general corporate purposes.
- Common warrants exercisable at $1.14 for 5 years; pre-funded warrants at $0.001.
- Company agreed to 45-day no-issuance and 180-day no variable-rate transaction lock-up.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1729427/000168316825003575/0001683168-25-003575-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1729427/000168316825003575/cns_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-25-003575

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer